These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33177101)

  • 21. Rheumatic diseases in intensive care unit patients with COVID-19.
    Moiseev S; Avdeev S; Brovko M; Yavorovskiy A; Novikov PI; Umbetova K; Akulkina L; Tsareva N; Fomin V
    Ann Rheum Dis; 2021 Feb; 80(2):e16. PubMed ID: 32434823
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients.
    De Lorenzis E; Parente P; Natalello G; Soldati S; Bosello SL; Barbara A; Sorge C; Axelrod S; Verardi L; Cerasuolo PG; Peluso G; Gemma A; Davoli M; Biliotti D; Bruzzese V; Goletti M; Di Martino M; D'Agostino MA
    Joint Bone Spine; 2023 Mar; 90(2):105497. PubMed ID: 36423782
    [No Abstract]   [Full Text] [Related]  

  • 23. Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: 'Online management of rheumatoid arthritis during COVID-19 pandemic' by Zhang
    Figueroa-Parra G; Gamboa-Alonso CM; Galarza-Delgado DA
    Ann Rheum Dis; 2021 Jan; 80(1):e5. PubMed ID: 32561606
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of COVID-19 pandemic on management of autoimmune and inflammatory diseases in Morocco.
    Wafa A; Hicham H; Hajar K; Mouna M; Zoubida MT; Mohamed A
    Pan Afr Med J; 2020; 37():240. PubMed ID: 33552358
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of arthritis and rheumatism in the United States.
    WOOLSEY TD
    Public Health Rep (1896); 1952 Jun; 67(6):505-12. PubMed ID: 14930183
    [No Abstract]   [Full Text] [Related]  

  • 26. Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review.
    Grange L; Guilpain P; Truchetet ME; Cracowski JL;
    Therapie; 2020; 75(4):335-342. PubMed ID: 32665090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic.
    Santos-Moreno P; Chavez-Chavez J; Hernández-Zambrano SM; Rivera-Triana DP; Castiblanco-Montañez RA; Aza A; Buitrago-Garcia D; Villarreal L; Rojas-Villarraga A
    Ann Rheum Dis; 2021 May; 80(5):e65. PubMed ID: 32586920
    [No Abstract]   [Full Text] [Related]  

  • 28. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.
    Costantino F; Bahier L; Tarancón LC; Leboime A; Vidal F; Bessalah L; Breban M; D'Agostino MA
    Joint Bone Spine; 2021 Jan; 88(1):105095. PubMed ID: 33152484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fears about COVID-19 and perceived risk among people with rheumatoid arthritis or ankylosing spondylitis following the initial lockdown in Aotearoa New Zealand.
    Treharne GJ; Johnstone G; Fletcher BD; Lamar RSM; White D; Stebbings S; Harrison A
    Musculoskeletal Care; 2022 Jun; 20(2):290-298. PubMed ID: 34388290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry.
    Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Østergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Nørgaard Agerbo J; Ziegler C; Lund Hetland M
    RMD Open; 2021 May; 7(2):. PubMed ID: 33941664
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of the COVID-19 Pandemic on the Employment of Canadian Young Adults With Rheumatic Disease: Findings From a Longitudinal Survey.
    Jetha A; Tucker LB; Chen C; Gignac MAM
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1146-1152. PubMed ID: 33973377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology.
    Wood PH; Henrard JC; Nissilä M
    Scand J Rheumatol Suppl; 1975; 12():133. PubMed ID: 1084558
    [No Abstract]   [Full Text] [Related]  

  • 34. Seroprevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Rheumatic Diseases other than Rheumatoid Arthritis.
    Saigal R; Bhakal SS; Goyal L; Goel AD
    J Assoc Physicians India; 2018 Apr; 66(4):26-8. PubMed ID: 30347947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Schulze-Koops
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2023 Jan; 82(1):e2. PubMed ID: 33127661
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic.
    Fragoulis GE; Evangelatos G; Arida A; Bournia VK; Fragiadaki K; Karamanakos A; Kravvariti E; Laskari K; Panopoulos S; Pappa M; Tektonidou MG; Sfikakis PP
    Ann Rheum Dis; 2021 Apr; 80(4):e60. PubMed ID: 32475830
    [No Abstract]   [Full Text] [Related]  

  • 37. Rheumatologic Aspects of the COVID-19 Pandemic: A Practical Resource for Physicians in Kuwait and the Gulf region as Recommended by the Kuwait Association of Rheumatology.
    Baron F; Alhajeri H; Abutiban F; Almutairi M; Alawadhi A; Aldei A; Alherz A; Ali Y; Alsayegh S; Dehrab A; Ghanem A; Hajji E; Hayat S; Saleh K; Shaikh-Alsooq R; Tarakmah H; Albasri A; Alenezi A; Alhadhood N; Alkanderi W; Almathkoori A; Almutairi N; Alturki A; Alkadi A; Behbahani H
    Curr Rheumatol Rev; 2022; 18(2):108-116. PubMed ID: 34620059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients'.
    Kermani TA
    Ann Rheum Dis; 2023 Oct; 82(10):e214. PubMed ID: 33478954
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals: a questionnaire survey.
    Eriksen TE; Dinesen WKH; Uhrenholt L; Dreyer L; Duch K; Kristensen S
    Rheumatol Int; 2022 May; 42(5):783-790. PubMed ID: 35359192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inflammatory rheumatic diseases in old age].
    Schmidt KL
    Z Rheumatol; 1982; 41(2):37-46. PubMed ID: 7048794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.